Literature DB >> 34188589

Restless Legs Syndrome in Multiple Sclerosis.

Taşkın Güneş1, Ufuk Emre2, Yüksel Erdal2, Osman Özgür Yalin2.   

Abstract

INTRODUCTION: The co-existence of Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED/WED) and multiple sclerosis (MS) is a common condition. For this reason, we aimed to evaluate the effects of RLS/WED and its relationship with MS.
METHODS: We evaluated the clinical features of 102 patients diagnosed with MS who were in follow-up between 2010 and 2015 in outpatient clinic. All the patients were evaluated for RLS/WED according to the revised International Restless Legs Syndrome Study Group (IRLSSG) diagnostic criteria. The Expanded Disability Status Scale (EDSS), Beck Depression Inventory, Beck Anxiety Inventory and Fatigue Severity Scale scores of all the patients were recorded. The IRLSSG 2003 severity scale was used to determine the degree of RLS/WED.
RESULTS: RLS/WED was detected in 30.4% (n=31) of the patients (MS-RLS/WED+), but not in 69.6% (n=71) (MS-RLS/WED-). The mean EDSS score of the MS-RLS/WED+ patients were 3.2±2.1 while the MS-RLS/WED-patients were 2.0±1.6. The incidences of depression, moderate or severe anxiety, fatigue and intestinal and bladder dysfunction in the MS-RLS/WED+ patients were significantly higher. Regarding to RLS/WED complaints, 32.2% were mild, 35.4% were moderate, 19.3% were severe and 12.9% were very severe. When the MS subgroups were evaluated the highest RLS/WED severity score was found in the secondary progressive MS group. In the patients with pyramidal symptoms and intestinal and bladder dysfunction, the mean RLS/WED severity was significantly higher. The mean RLS/WED severity score was also significantly higher in those with depression and anxiety. The RLS/WED severity was significantly correlated with the number of pyramidal attacks and the EDSS score.
CONCLUSION: Restless legs syndrome is a cause of depression, anxiety and fatigue and has negative effects on MS patients. Therefore, after the diagnosis of MS, the RLS/WED symptoms and signs should be determined, as soon as possible, in addition to the other MS symptoms. The treatment of this condition should be started early. Copyright:
© 2021 Turkish Neuropsychiatric Society.

Entities:  

Keywords:  Restless legs syndrome; fatigue; multiple sclerosis

Year:  2019        PMID: 34188589      PMCID: PMC8214741          DOI: 10.29399/npa.23429

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  16 in total

Review 1.  Contribution of magnetic resonance imaging to the diagnosis and monitoring of multiple sclerosis.

Authors:  M A Rocca; N Anzalone; A Falini; M Filippi
Journal:  Radiol Med       Date:  2012-03-19       Impact factor: 3.469

2.  Restless legs syndrome in Czech patients with multiple sclerosis: an epidemiological and genetic study.

Authors:  J Vávrová; D Kemlink; K Sonka; E Havrdová; D Horáková; B Pardini; B Müller-Myhsok; J Winkelmann
Journal:  Sleep Med       Date:  2012-05-19       Impact factor: 3.492

Review 3.  Restless legs syndrome in multiple sclerosis.

Authors:  Mariusz Sieminski; Jacek Losy; Markku Partinen
Journal:  Sleep Med Rev       Date:  2014-10-12       Impact factor: 11.609

4.  High prevalence of restless legs syndrome in multiple sclerosis.

Authors:  M Manconi; M Fabbrini; E Bonanni; M Filippi; M Rocca; L Murri; L Ferini-Strambi
Journal:  Eur J Neurol       Date:  2007-05       Impact factor: 6.089

Review 5.  Cognitive dysfunction in multiple sclerosis: Assessment, imaging, and risk factors.

Authors:  Mitchell T Wallin; Jeffrey A Wilken; Robert Kane
Journal:  J Rehabil Res Dev       Date:  2006 Jan-Feb

Review 6.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

Authors:  Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

7.  High false-positive rate of questionnaire-based restless legs syndrome diagnosis in multiple sclerosis.

Authors:  V Mery; R J Kimoff; I Suarez; A Benedetti; M Kaminska; A Robinson; Y Lapierre; A Bar-Or; D A Trojan
Journal:  Sleep Med       Date:  2015-03-06       Impact factor: 3.492

8.  Restless legs syndrome in Iranian patients with multiple sclerosis.

Authors:  Shahnaz Miri; Mohammad Rohani; Mohammad Ali Sahraian; Babak Zamani; Gholam Ali Shahidi; Amin Sabet; Maziar Moradi-Lakeh; Mohammad Bodaghabadi
Journal:  Neurol Sci       Date:  2012-09-09       Impact factor: 3.307

Review 9.  Restless legs syndrome associated with major diseases: A systematic review and new concept.

Authors:  Claudia Trenkwalder; Richard Allen; Birgit Högl; Walter Paulus; Juliane Winkelmann
Journal:  Neurology       Date:  2016-03-04       Impact factor: 9.910

10.  Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study.

Authors:  Mauro Manconi; Luigi Ferini-Strambi; Massimo Filippi; Enrica Bonanni; Alfonso Iudice; Luigi Murri; Gian Luigi Gigli; Lara Fratticci; Giovanni Merlino; Giovanni Terzano; Franco Granella; Liborio Parrino; Rosalia Silvestri; Irene Aricò; Vincenzo Dattola; Giovanna Russo; Carmela Luongo; Alessandro Cicolin; Antonella Tribolo; Paola Cavalla; Mariantonietta Savarese; Maria Trojano; Salvatore Ottaviano; Fabio Cirignotta; Valentina Simioni; Fabrizio Salvi; Fiorella Mondino; Franco Perla; Giorgia Chinaglia; Cristina Zuliani; Edward Cesnik; Enrico Granieri; Fabio Placidi; Maria Giuseppina Palmieri; Raffaele Manni; Michele Terzaghi; Roberto Bergamaschi; Raffaele Rocchi; Monica Ulivelli; Sabina Bartalini; Raffaele Ferri; Salvatore Lo Fermo; Emilio Ubiali; Massimo Viscardi; Mariarosa Rottoli; Lino Nobili; Alessandra Protti; Franco Ferrillo; Marta Allena; Gianluigi Mancardi; Biancamaria Guarnieri; Francesco Londrillo
Journal:  Sleep       Date:  2008-07       Impact factor: 5.849

View more
  1 in total

Review 1.  The prevalence of restless legs syndrome (RLS) in patients with multiple sclerosis (MS): a systematic review and meta-analysis-an update.

Authors:  Alireza Zali; Mahsa Motavaf; Saeid Safari; Narges Ebrahimi; Mahsa Ghajarzadeh; Reza Jalili Khoshnood; Omid Mirmosayyeb
Journal:  Neurol Sci       Date:  2022-09-05       Impact factor: 3.830

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.